Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001651308-23-000097
Filing Date
2023-06-20
Accepted
2023-06-20 19:00:29
Documents
1
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_168730201626632.html 4  
1 FORM 4 wf-form4_168730201626632.xml 4 7392
  Complete submission text file 0001651308-23-000097.txt   8859
Mailing Address C/O KINIKSA PHARMACEUTICALS, LTD. CLARENDON HOUSE, 2 CHURCH STREET HAMILTON D0 HM11
Business Address
Malley Thomas (Reporting) CIK: 0001403322 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37686 | Film No.: 231026973

Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Issuer) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations